Since the TGFβ pathway promotes tumor progression in the context of in vivo tumor microenvironments by suppressing and evading the immune system39, immune checkpoint inhibitors might be relevant for DIPG. The gene discussed is TGFB1; the disease is diffuse intrinsic pontine glioma.